HK Stock MarketDetailed Quotes

01789 AK MEDICAL

Watchlist

4.720
-0.030-0.63%

Market Closed Dec 20 16:08 CST

5.30BMarket Cap25.65P/E (TTM)

AK MEDICAL Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

(FY)Dec 31, 2020

(Q6)Jun 30, 2020

(FY)Dec 31, 2019

Turnover

1.30%657.1M

3.97%1.09B

22.11%648.69M

38.17%1.05B

18.67%531.21M

-26.46%761.44M

-6.54%447.63M

11.73%1.04B

9.41%478.98M

54.31%926.71M

Operating income

1.30%657.1M

3.97%1.09B

22.11%648.69M

38.17%1.05B

18.67%531.21M

-26.46%761.44M

-6.54%447.63M

11.73%1.04B

9.41%478.98M

54.31%926.71M

Cost of sales

-4.65%-258.62M

-0.91%-419.38M

-28.26%-247.12M

-58.48%-415.61M

-38.32%-192.68M

18.26%-262.25M

2.35%-139.3M

-13.19%-320.85M

-7.10%-142.66M

-47.88%-283.45M

Operating expenses

-4.65%-258.62M

-0.91%-419.38M

-28.26%-247.12M

-58.48%-415.61M

-38.32%-192.68M

18.26%-262.25M

2.35%-139.3M

-13.19%-320.85M

-7.10%-142.66M

-47.88%-283.45M

Gross profit

-0.77%398.48M

5.98%674.49M

18.62%401.57M

27.49%636.44M

9.80%338.54M

-30.14%499.19M

-8.32%308.33M

11.08%714.53M

10.42%336.32M

57.32%643.25M

Selling expenses

3.75%-113.01M

-21.49%-218.81M

-17.74%-117.41M

3.86%-180.11M

-26.67%-99.71M

-21.57%-187.35M

-25.45%-78.72M

12.11%-154.1M

25.66%-62.75M

-42.69%-175.33M

Administrative expenses

3.81%-72.31M

-12.79%-133.44M

-37.84%-75.17M

-12.34%-118.31M

-6.86%-54.54M

-26.86%-105.32M

-33.39%-51.04M

9.96%-83.02M

19.55%-38.26M

-24.39%-92.2M

Research and development expenses

4.15%-63.58M

-23.69%-137.13M

-21.92%-66.33M

1.95%-110.87M

-5.15%-54.4M

-7.71%-113.07M

-17.85%-51.74M

-30.36%-104.97M

-24.95%-43.9M

-76.61%-80.53M

Impairment and provision

----

---18.36M

----

---8.85M

----

-Goodwill impairment

----

---18.36M

----

---8.85M

----

Special items of operating profit

177.10%2.9M

135.59%26.37M

-78.85%1.05M

87.21%11.19M

138.27%4.96M

12.11%5.98M

120.57%2.08M

-73.77%5.33M

-93.93%943K

311.37%20.33M

Operating profit

6.11%152.49M

-3.86%211.48M

6.58%143.71M

121.23%219.98M

4.60%134.84M

-73.05%99.44M

-32.98%128.92M

16.93%368.93M

25.71%192.36M

84.27%315.52M

Financing income

-29.75%10.03M

-3.31%19.63M

-2.28%14.28M

122.59%20.31M

442.55%14.61M

18.77%9.12M

-40.35%2.69M

30.61%7.68M

31.44%4.52M

79.68%5.88M

Earning before tax

2.87%162.52M

-3.82%231.12M

5.71%157.99M

121.35%240.29M

13.56%149.45M

-71.17%108.56M

-33.15%131.61M

17.18%376.61M

25.84%196.87M

84.18%321.4M

Tax

8.43%-23.27M

-37.99%-49.01M

-8.51%-25.41M

-122.82%-35.52M

-16.35%-23.42M

74.54%-15.94M

40.80%-20.13M

-15.05%-62.6M

-26.42%-34M

-84.04%-54.41M

After-tax profit from continuing operations

5.04%139.25M

-11.07%182.1M

5.19%132.57M

121.09%204.77M

13.05%126.03M

-70.50%92.62M

-31.55%111.48M

17.61%314.01M

25.72%162.87M

84.21%266.99M

Earning after tax

5.04%139.25M

-11.07%182.1M

5.19%132.57M

121.09%204.77M

13.05%126.03M

-70.50%92.62M

-31.55%111.48M

17.61%314.01M

25.72%162.87M

84.21%266.99M

Profit attributable to shareholders

5.04%139.25M

-11.07%182.1M

5.19%132.57M

121.09%204.77M

13.05%126.03M

-70.50%92.62M

-31.55%111.48M

17.61%314.01M

25.72%162.87M

84.21%266.99M

Basic earnings per share

0.00%0.12

-11.11%0.16

9.09%0.12

125.00%0.18

10.00%0.11

-71.43%0.08

-33.33%0.1

7.69%0.28

25.00%0.15

85.71%0.26

Diluted earnings per share

0.00%0.12

-11.11%0.16

9.09%0.12

125.00%0.18

10.00%0.11

-71.43%0.08

-33.33%0.1

12.00%0.28

25.00%0.15

78.57%0.25

Currency Unit

CNY

Accounting Standards

IAS

Audit Opinions

Unqualified Opinion

Auditor

KPMG

	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021	(FY)Dec 31, 2020	(Q6)Jun 30, 2020	(FY)Dec 31, 2019
Turnover	1.30%657.1M	3.97%1.09B	22.11%648.69M	38.17%1.05B	18.67%531.21M	-26.46%761.44M	-6.54%447.63M	11.73%1.04B	9.41%478.98M	54.31%926.71M
Operating income	1.30%657.1M	3.97%1.09B	22.11%648.69M	38.17%1.05B	18.67%531.21M	-26.46%761.44M	-6.54%447.63M	11.73%1.04B	9.41%478.98M	54.31%926.71M
Cost of sales	-4.65%-258.62M	-0.91%-419.38M	-28.26%-247.12M	-58.48%-415.61M	-38.32%-192.68M	18.26%-262.25M	2.35%-139.3M	-13.19%-320.85M	-7.10%-142.66M	-47.88%-283.45M
Operating expenses	-4.65%-258.62M	-0.91%-419.38M	-28.26%-247.12M	-58.48%-415.61M	-38.32%-192.68M	18.26%-262.25M	2.35%-139.3M	-13.19%-320.85M	-7.10%-142.66M	-47.88%-283.45M
Gross profit	-0.77%398.48M	5.98%674.49M	18.62%401.57M	27.49%636.44M	9.80%338.54M	-30.14%499.19M	-8.32%308.33M	11.08%714.53M	10.42%336.32M	57.32%643.25M
Selling expenses	3.75%-113.01M	-21.49%-218.81M	-17.74%-117.41M	3.86%-180.11M	-26.67%-99.71M	-21.57%-187.35M	-25.45%-78.72M	12.11%-154.1M	25.66%-62.75M	-42.69%-175.33M
Administrative expenses	3.81%-72.31M	-12.79%-133.44M	-37.84%-75.17M	-12.34%-118.31M	-6.86%-54.54M	-26.86%-105.32M	-33.39%-51.04M	9.96%-83.02M	19.55%-38.26M	-24.39%-92.2M
Research and development expenses	4.15%-63.58M	-23.69%-137.13M	-21.92%-66.33M	1.95%-110.87M	-5.15%-54.4M	-7.71%-113.07M	-17.85%-51.74M	-30.36%-104.97M	-24.95%-43.9M	-76.61%-80.53M
Impairment and provision	----	----	----	---18.36M	----	----	----	---8.85M	----	----
-Goodwill impairment	----	----	----	---18.36M	----	----	----	---8.85M	----	----
Special items of operating profit	177.10%2.9M	135.59%26.37M	-78.85%1.05M	87.21%11.19M	138.27%4.96M	12.11%5.98M	120.57%2.08M	-73.77%5.33M	-93.93%943K	311.37%20.33M
Operating profit	6.11%152.49M	-3.86%211.48M	6.58%143.71M	121.23%219.98M	4.60%134.84M	-73.05%99.44M	-32.98%128.92M	16.93%368.93M	25.71%192.36M	84.27%315.52M
Financing income	-29.75%10.03M	-3.31%19.63M	-2.28%14.28M	122.59%20.31M	442.55%14.61M	18.77%9.12M	-40.35%2.69M	30.61%7.68M	31.44%4.52M	79.68%5.88M
Earning before tax	2.87%162.52M	-3.82%231.12M	5.71%157.99M	121.35%240.29M	13.56%149.45M	-71.17%108.56M	-33.15%131.61M	17.18%376.61M	25.84%196.87M	84.18%321.4M
Tax	8.43%-23.27M	-37.99%-49.01M	-8.51%-25.41M	-122.82%-35.52M	-16.35%-23.42M	74.54%-15.94M	40.80%-20.13M	-15.05%-62.6M	-26.42%-34M	-84.04%-54.41M
After-tax profit from continuing operations	5.04%139.25M	-11.07%182.1M	5.19%132.57M	121.09%204.77M	13.05%126.03M	-70.50%92.62M	-31.55%111.48M	17.61%314.01M	25.72%162.87M	84.21%266.99M
Earning after tax	5.04%139.25M	-11.07%182.1M	5.19%132.57M	121.09%204.77M	13.05%126.03M	-70.50%92.62M	-31.55%111.48M	17.61%314.01M	25.72%162.87M	84.21%266.99M
Profit attributable to shareholders	5.04%139.25M	-11.07%182.1M	5.19%132.57M	121.09%204.77M	13.05%126.03M	-70.50%92.62M	-31.55%111.48M	17.61%314.01M	25.72%162.87M	84.21%266.99M
Basic earnings per share	0.00%0.12	-11.11%0.16	9.09%0.12	125.00%0.18	10.00%0.11	-71.43%0.08	-33.33%0.1	7.69%0.28	25.00%0.15	85.71%0.26
Diluted earnings per share	0.00%0.12	-11.11%0.16	9.09%0.12	125.00%0.18	10.00%0.11	-71.43%0.08	-33.33%0.1	12.00%0.28	25.00%0.15	78.57%0.25
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS
Audit Opinions	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion
Auditor	--	KPMG	--	KPMG	--	KPMG	--	KPMG	--	KPMG

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending HK Stocks